| Metric | შპს კრომოს ფარმა საქართველო | შპს მედლაბ 2024 |
|---|---|---|
| Growth | ||
| Revenue | ₾2.1m | ₾1.8m |
| Revenue growth | — | — |
| Profitability | ||
| EBITDA | ₾59k | ₾582k |
| EBITDA margin | 2.8% | 33.0% |
| Net profit | ₾24k | ₾586k |
| Net margin | 1.1% | 33.2% |
| Balance sheet | ||
| Total assets | ₾360k | ₾1.3m |
| Total equity | ₾317k | ₾586k |
| ROE | 7.5% | 100.0% |